Insider · CIK 0001334483
Alexander Y Tokman
Files at NDRA (ENDRA Life Sciences Inc.). First filing -, latest -.
In brief
Alexander Y Tokman files SEC Form 4 as CEO and director at NDRA (ENDRA Life Sciences Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Alexander Y Tokman has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 2 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 2, 2026 | NDRA ENDRA Life Sciences Inc. | AGrant or award Common Stock | +26,921 | $0.00 | $0 | 101,926 | Mar 4, 2026 |
| Jan 21, 2026 | NDRA ENDRA Life Sciences Inc. | AGrant or award Common Stock | +75,000 | $0.00 | $0 | 75,005 | Jan 23, 2026 |
Questions about Alexander Y Tokman
Answered from the filings on this page, as of the latest one.
Is Alexander Y Tokman buying or selling?
Alexander Y Tokman has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Alexander Y Tokman's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Alexander Y Tokman has 0.
Where does Alexander Y Tokman file Form 4?
Alexander Y Tokman has filed Form 4 at NDRA (ENDRA Life Sciences Inc.) as Chief Executive Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.